Authors

  • Yusupova U.M.

Keywords:

dyslipidemia, infertility, polycystic ovaries, overweight.

References

And Dedov. I., Butrova S. A. Polycystic ovary syndrome and metabolic syndrome //Obesity and metabolism. – 2006. – №. 1. – Pp. 30-40.

Grigoryan O. R., Zhemaite N. S., Volevodz N. N., Andreeva E. N., Melnichenko G. A., Dedov I. I. Long-term consequences of polycystic ovary syndrome //Therapeutic Archive. – 2017. - no. 89. – No. 10. – pp. 75-79.

Guo F., Gong Z., Fernando T., Zhang L., Zhu H. and Shi Yu. Lipid profiles in various characteristics of women with PCOS and the relationship between dyslipidemia and states of metabolic disorders: a retrospective study among the Chinese population //Frontiers of endocrinology. – 2022. - Vol. 13. pp. 1-9.

Holte J., Berg T., Gennarelli G., Wade L. Independent effect of polycystic ovary syndrome and obesity on the concentration of gonadotropins and sex steroids in serum in premenopausal women //Clinical endocrinology. – 1994. – Issue 41. - No. 4. – pp. 473-481.

Legro R. S., Kunselman A. R., Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome //American Medical Journal. – 2001. – p. 111. – No. 8. - p. 607-613.

Liu K., Xie Yu. J., Qu L. H., Zhang M. H. and Mo Z. S. Participation of dyslipidemia in the development of polycystic ovary syndrome // Taiwan Journal of Obstetrics and Gynecology. – 2019. – № 58. – № 4. - Pp. 447-453.

Wilde R. A., Carmina E., Diamanti-Candarakis E., Dokras A., Escobar-Morreale H. F., Futterwaite U.,...and Dumesik D. A. Assessment of cardiovascular risk and prevention of cardiovascular diseases in women with polycystic ovary syndrome: a consensus statement of the World Health Organization. Society of Androgen excess and polycystic Ovary syndrome (AE-PCOS) // Journal of Clinical Endocrinology and Metabolism. - 2010. – p. 95. – No. 5. – p. 2038-2049.